Relpax

Product manufactured by U.s. Pharmaceuticals

Application Nr Approved Date Route Status External Links
NDA021016 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Relpax Is Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. Limitations Of Use: Use Only If A Clear Diagnosis Of Migraine Has Been Established. If A Patient Has No Response To The First Migraine Attack Treated With Relpax, Reconsider The Diagnosis Of Migraine Before Relpax Is Administered To Treat Any Subsequent Attacks. Relpax Is Not Intended For The Prevention Of Migraine Attacks. Safety And Effectiveness Of Relpax Have Not Been Established For Cluster Headache. Relpax Is A Serotonin (5-Ht 1b/1d ) Receptor Agonist (triptan) Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults ( 1 ) Limitations Of Use: Use Only After A Clear Diagnosis Of Migraine Has Been Established ( 1 ) Not Indicated For The Prophylactic Therapy Of Migraine ( 1 ) Not Indicated For The Treatment Of Cluster Headache ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Eletriptan Hydrobromide ELETRIPTAN HYDROBROMIDE ZINC3823475

Comments